Shortage of intravenous immunoglobulin

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 2, 1998, Pages 97-100

  Milgrom, H ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MACROGOL;

ABDOMINAL PAIN; ANAPHYLAXIS; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; BACKACHE; CHILL; CHRONIC LYMPHATIC LEUKEMIA; CREUTZFELDT JAKOB DISEASE; DRUG MANUFACTURE; DRUG SAFETY; EDITORIAL; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGAMMAGLOBULINEMIA; IMMUNOPATHOLOGY; KIDNEY TUBULE NECROSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOEMBOLISM; VOMITING; X LINKED AGAMMAGLOBULINEMIA;

EID: 0031718550     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62792-5     Document Type: Editorial

References (31)

1. D Scheckelhoff Public Health 2000: Immune globulin shortages: causes and cures May 7, 1998 American Society of Health-System Pharmacists Washington, DC http://@ashp.org .
2. C Lamb What has caused the current shortages of plasma derivatives and what can be done to correct this situation? 1998 Food and Drug Administration, Department of Health and Human Services Washington, DC http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
3. K Eichenwald Shortage of plasma drug creates health care crisis April 26, 1998 The New York Times New York 1 20.
4. Kreck C. Running dry. The Denver Post. Denver, March 12, 1998:E1, E4.
5. J Epstein K Zoon “Dear Doctor” [Letter] 1998 Food and Drug Administration, Department of Health and Human Services Rockville, MD http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
6. MC Dalakas Intravenous immune globulin therapy for neurologic diseases Ann Intern Med 126 1997 721 730
7. FG van der Meche PA van Doorn The current place of high-dose immunoglobulins in the treatment of neuro-muscular disorders Muscle Nerve 20 1997 136 147
8. M Ballow Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases J Allergy Clin Immunol 100 1997 151 157
9. EW Gelfand LP Landwehr B Esterl B Mazer Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases Clin Exp Immunol 104 Suppl 1 1996 61 66
10. B Mazer E Gelfand An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma J Allergy Clin Immunol 87 1991 976 983
11. CM Lockwood New treatment strategies for systemic vasculitis: the role of intravenous immune globulin therapy Clin Exp Immunol 104 Suppl 1 1996 77 82
12. R Buckley R Schiff The use of intravenous globulin in immunodeficiency diseases N Engl J Med 325 1991 110 117
13. LW Klassen LH Calabrese RM Laxer Intravenous immunoglobulin in rheumatic disease Rheum Dis Clin N Am 22 1996 155 173
14. ED Gomperts Gammagard and reported hepatitis C virus episodes Clin Ther 18 Suppl B 1996 3 8
15. PL Yap The viral safety of intravenous immune globulin Clin Exp Immunol 104 Suppl 1 1996 35 42
16. K Zoon Disposition of products derived from donors diagnosed with, or at known high risk for, Creutzfeldt-Jakob disease August 8, 1995 Food and Drug Administration, Department of Health and Human Services Rockville, MD
17. H Budka A Aguzzi P Brown Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol 5 1995 459 466
18. RG Will JW Ironside M Zeidler A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 1996 921 925
19. CI Lasmezas JP Deslys R Demalmay BSE transmission to macaques [Letter] Nature 381 1996 743 744
20. R Holman A Khan E Belay L Schoenberger Creutzfeldt-Jakob disease in the United States, 1979–1994: using national mortality data to assess the possible occurrence of variant cases Emerging Infect Dis 2 1996 333 337
21. N Heye S Hensen N Muller Creutzfeldt-Jakob disease and blood transfusion [Letter] Lancet 343 1994 298 299
22. M Ricketts N Cashman E Stratton S El Saadany Is Creutzfeldt-Jakob disease transmitted in blood? Emerging Infect Dis 1997 http://www.cdc.gov/ncidod/EID/vol3no2/rickettshtm .
23. E Operskalski J Mosley Pooled plasma derivatives and Creutzfeldt-Jakob disease [Letter] Lancet 346 1995 1224
24. D Tankersly What has caused the current shortages of plasma derivatives and what can be done to correct this situation? 1998 Food and Drug Administration, Department of Health and Human Services Washington, DC http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
25. K Zoon Revised precautionary measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) by blood and blood products December 11, 1996 Food and Drug Administration Department of Health and Human Services Rockville, MD
26. P Robert What has caused the current shortages of plasma derivatives and what can be done to correct this situation? 1998 Food and Drug Administration, Department of Health and Human Services Washington, DC http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
27. Y Lee D Woodfield R Douglas Clinical usage of intravenous immunoglobulins in Auckland NZ Med J 110 1997 48 50
28. M Weinstein What has caused the current shortages of plasma derivatives and what can be done to correct this situation? 1998 Food and Drug Administration, Department of Health and Human Services Washington, DC http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
29. G Stadtmauer C Cunningham-Rundles Outcome analysis and cost assessment in immunologic disorders JAMA 278 1997 2018 2023
30. T Moran What has caused the current shortages of plasma derivatives and what can be done to correct this situation? 1998 Food and Drug Administration, Department of Health and Human Services Washington, DC http://www.os.dhhs.gov/partner/bloodsafety/apr28_98.htm .
31. Sc)-specific epitope defined by a monoclonal antibody Nature 390 1997 74 77